Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Debio 1143 with Chemoradiotherapy in Head and Neck Cancer
NCT02022098Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Oct 2013
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of xevinapant in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Debiopharm. Started Oct 2013; status: completed.
02
Drugs
xevinapant
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02022098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022098.